UNH: Leadership change

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Madeline Bell as independent director On November 9, 2026, UnitedHealth Group Incorporated (the “Company”) issued a press release announcing the appointment of Madeline Bell to serve as an independent director of the Company, effective November 3, 2026. Ms. Bell has not yet been appointed to any committees of the Company's Board of Directors. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Ms. Bell will receive compensation for her services as a director in accordance with the Company’s standard compensation program for non-employee directors as amended from time to time, the material terms of which are described in the Company’s 2026 proxy statement. In accordance with the Company’s customary practice, the Company is entering into its standard form of indemnification agreement with Ms. Bell, which requires the Company to indemnify her against certain liabilities that may arise as a result of her status or service as a director. The foregoing description is qualified in its entirety by the full text of the form of Indemnification Agreement, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 1, 2015. There are no arrangements or understandings between Ms. Bell and any other person pursuant to which Ms. Bell was appointed to serve on the Board of Directors. Ms. Bell has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Item 9.01. Financial Statements and Exhibits. Exhibit Description 99.1 Press release dated November 9, 2026 104 Cove